双价外壳蛋白基因植物表达载体的构建及马铃薯转基因植株的鉴定

在克隆了马铃薯Ｘ病毒（ＰＶＸ）、马铃薯Ｙ 病毒（ＰＶＹ）和马铃薯卷叶病毒（ＰＬＲＶ）的外壳蛋白基因的基础上,构建同时包含ＰＶＸ和ＰＶＹ 与ＰＶＹ 和ＰＬＲＶ 两个外壳蛋白基因植物表达框架的表达载体,通过农杆菌（Ａｇｒｏｂａｃｔｅｒｉｕｍ ｔｕｍｅｆａｃｉｅｎｓ）介导转化烟草（Ｎｉｃｏｔｉａｎａｔａｂａｃｕｍ ）和生产上常用的几个马铃薯（Ｓｏｌａｎｕｍ ｔｕｂｅｒｏｓｕｍ ）优良品种：“Ｆａｖｏｒｉｔａ”、“虎头”、“克４”。经ＰＣＲ检测证明外源基因已整合到植物的染色体上,得到批量转基因植株。在转ＰＶＸ＋ＰＶＹ 外壳蛋白基因的烟草上接种ＰＶＸ （５ μｇ／ｍ Ｌ）、ＰＶＹ（２０ μｇ／ｍ Ｌ）病毒,得到有一定抗性的植株     

表达马铃薯X病毒和Y病毒双价外壳蛋白基因马铃薯植株的抗病性

表达马铃薯Ｘ病毒（ＰＶＸ）和马铃薯Ｘ病毒（ＰＶＹ）双价外壳蛋白（ＣＰ）基因的马铃薯虎头和克新４号,用机械摩擦同时接种ＰＶＸ和ＰＶＹ后,通过症状观察,植株中ＰＶＸ和ＰＶＹ的ＥＬＩＳＡ检测结果表明,转基因头虎头和克新４号的多数株系的平均病毒含量均明显低于未转基因的对照植株,不同时期病毒测定结果表明,许多株系病毒积累缓慢,延迟发病,说明转ＰＶＸ,ＰＶＹ双价ＣＰ基因的马铃薯,对ＰＶＸ和ＰＶＹ复合侵染发生不     

表达马铃薯Y病毒外壳蛋白的转基因烟草的抗病性研究

将马铃薯Ｙ病毒中国分离物（ＰＶＴ－Ｃ）的外壳蛋白（ＣＰ）基因,在土壤农杆菌ＬＢＡ４４０４的介导下,转化烟草生产品种ＮＣ８９,获得了６个烟草株系。通过抗性分析发现,６个株系中有一个株系在２００μｇ／ｍｌＰＶＹ－Ｃ的攻毒下,仍未发病,分子检测发现,转基因植物中抗性产生的程度并不是同ＰＶＹ－Ｃ外壳蛋白的表达水平成正相关。     

马铃薯Y病毒普通系外壳蛋白基因在大肠杆菌中的表达

将马铃薯Ｙ病毒普通系（ＰＶＹ０）的外壳蛋白基因克隆到表达质粒ｐＭＡＬｃ２中,构建这一基因在大肠杆菌中的表达载体ｐＭＡＬｃ２ＰＶＹ０ＣＰ。ＳＤＳＰＡＧＥ及Ｗｅｓｔｅｒｎｂｌｏｔｉｎｇ检测结果表明,这一表达栽体在Ｅ．ｃｏｌｉＤＨ５α中经ＩＰＴＧ诱导可表达分子量为７１．８ｋＤａ的特异性融合蛋白。以ａｍｙｌｏｓｅｒｅｓｉｎ亲合柱层析纯化这一融合蛋白为抗原,免疫家兔制备了效价为１∶１０２４的特异性抗血清。用该抗血清可通过对流免疫电泳、免疫双扩散及Ｗｅｓｔｅｒｎｂｌｏｔｉｎｇ对ＰＶＹ进行检测     

马铃薯Y病毒外壳蛋白基因在转基因马铃薯中的表达

ＰＶＹ是马铃薯Ｙ病毒组的典型成员,主要感染马铃薯、番茄、辣椒和烟草等。近年来,利用植物基因工程手段获得了不少抗病毒转基因工程植物,为培育抗病毒作物新品种提供了新途径［１］。病毒外壳蛋白基因导入并使之在植物中表达可获得抗相应病毒的转基因植物,已在烟草、番茄、马铃薯、苜蓿、黄瓜和番木瓜等植物中获得成功［１～３］。本室已成功地对在我国流行的ＰＶＹＮ株系外壳蛋白基因进行了克隆及序列测定［４］,在此基础上,我们构建了植物表达中间载体,通过土壤农杆菌介导的叶盘法转化马铃薯,获得了大量转基因植株。分子检测证明…     

马铃薯卷叶病毒基因间隔区转化的马铃薯抗病性研究

将本室合成、克隆的马铃薯卷叶病毒（ＰｏｔａｔｏＬｅａｆｒｏｌＶｉｒｕｓ,ＰＬＲＶ）中国分离株的基因间隔区（ｉｎｔｅｒｇｅｎｉｃｓｅｑｕｅｎｃｅ,ＩＳ）双链ｃＤＮＡ以正、反向两种方式分别构建于转化载体ｐＲＯＫ２中,通过致瘤农杆菌介导,以马铃薯叶圆片为转化材料,转化马铃薯栽培品种Ｄｅｓｉｒｅ,获得了转基因植株。卡那霉素抗性分析和ＰＣＲ检测目的基因,证明ＰＬＲＶＩＳ双链ｃＤＮＡ已经整合到转基因马铃薯的染色体基因组中。将转基因植株移栽网棚用蚜虫接种ＰＬＲＶ,观察症状并用酶联免疫吸附测定（ＥＬＩＳＡ）检测转基因植株中ＰＬＲＶ含量。结果表明,表达ＰＬＲＶＩＳ正意和反意ＲＮＡ的转基因植株,接种病毒后表现无症状或症状轻微,ＰＬＲＶ平均滴度均较未转基因对照植株低。表达正意ＲＮＡ的转基因植株ＰＬＲＶ滴度降低４３％～７２％,表达反意ＲＮＡ的转基因植株ＰＬＲＶ滴度降低７２％～８６％,由此可见,表达ＰＬＲＶＩＳ反意ＲＮＡ的转基因马铃薯对ＰＬＲＶ抗性较强。     

马铃薯Y病毒NIb复制酶基因在转录水平介导的相对广谱抗病性

在大肠杆菌中表达了马铃薯Ｙ病毒中国分离物（ＰＶＹ－Ｃ）复制酶ＮＩｂ基因,并制备了其抗血清。利用ＰＣＲ定点突变方法使ＮＩｂ基因移码－１位,构建了移码－１位ＮＩｂ基因（ＵＮ）的植物表达载体。通过土壤农杆菌（Ａｇｒｏｂａｃｔｅｒｉｕｍ ｔｕｍｅｆａｃｉｅｎｓ ＬＢＡ４４０４）介导转化烟草ＮＣ８９,获得５１株再生植株。对再生植株的分子检测结果表明,转基因烟草中检测到ＵＮ基因相应的ＲＮＡ转录产物,３推测该基     

黄瓜花叶病毒（CMV）运动蛋白基因介导的抗病性

利用Ｆｎｙ＿ＣＭＶ株系ＲＮＡ３ｃＤＮＡ克隆,构建了含有全长和编码区缺失５０１个核苷酸的运动蛋白（ＭＰ）基因植物表达载体ｐＢＭＰＲ和ｐＢＭＰＫ。在土壤农杆菌（Ａｇｒｏｂａｃｔｅｒｉｕｍｔｕｍｅｆａｃｉｅｎｓ（ＳｍｉｔｈｅｔＴｏｗｎｓｅｎｄ）Ｃｏｎｎ）ＬＢＡ４４０４介导下转化烟草（ＮｉｃｏｔｉａｎａｔａｂａｃｕｍＬ．）品种“ＮＣ８９”,分别经Ｓｏｕｔｈｅｒｎｂｌｏｔｉｎｇ、ＲＴ＿ＰＣＲ或Ｗｅｓｔｅｒｎｂｌｏｔｉｎｇ分析,外源基因已整合到再生植株中并得到表达。抗病性分析表明,含有缺失型ＭＰ基因的Ｒ０代转基因植株抗性较好,接种５０ｄ后,１０株转化植株中仍有５株不表现症状。在自然发病条件下,这５个含有缺失型ＭＰ基因转基因株系在Ｒ１代都表现了一定的抗病性。抗性主要表现为症状出现推迟,严重度减轻。利用ＰＣＲ筛选、种子卡那霉素抗性试验和温室抗病性测定等方法,初步认为Ｒ２代转基因烟草Ｋ＿６＿５株系为转基因抗病纯合系。而含有全长ＭＰ基因的Ｒ０代转化植株,前期没有表现明显的抗病性,但在接种４０ｄ后部分发病植株有恢复健康的趋势。     

抗芜菁花叶病毒转基因甘蓝型油菜的研究

以子叶柄为材料,建立了甘蓝型油菜（ＢｒａｓｓｉｃａｎａｐｕｓＬ．）双低品种的再生体系。通过子叶柄与农杆菌（ＡｇｒｏｂａｃｔｅｒｉｕｍｔｕｍｅｆａｃｉｅｎｓＬＢＡ４４０４）共培养,将表达载体ｐＢＴｕ中芜菁花叶病毒外壳蛋白（ＴｕＭＶ－ＣＰ）基因以整合方式导入甘蓝型油菜,然后用卡那霉素进行筛选,获得了油菜再生植株。经ＰＣＲ特异性扩增、点杂交和Ｓｏｕｔｈｅｒｎ印迹分析,证明再生植株基因组ＤＮＡ中整合了ＴｕＭＶ－ＣＰ基因。攻毒实验表明,有ＴｕＭＶ－ＣＰ基因插入的工程油菜对ＴｕＭＶ均有不同程度的抗性。     

马铃薯X病毒外壳蛋白基因在转基因烟草植株中的表达及抗病

通过根癌农杆菌介导的叶盘法,将马铃薯Ｘ病毒外壳蛋白基因导入烟草细胞并获得大量再生的转基因烟草植株。经胭脂碱检测、酶联免疫分析和Ｗｅｓｔｅｒｎ ｂｌｏｔ分析,证明已获得了具有马铃薯Ｘ病毒外壳蛋白基因表达的转基因烟草。用２μｇ／ｍｌ的ＰＶＸ磨擦接种烟草,８天后进行观察,发现对照植株开始发病,而转基因烟草植株在２０后才开始发病,有的转基因烟草植株在整个生长期中都不得病。对ＰＶＸＣＰ基因表达量较高的４株植     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).